The lean NAFLD-related HCC cohort patients were predictably low in number ( n = 23) and their median survival, while lower at 1.44 years (95%CI: 0.39-) did not reach statistical significance compared to the overweight (2.95 years, 95%CI 1.5-4.14), obese class I (1.99 years 1.42-) and obese class II (2.23 years, 95%CI 1.54-2.87) ( P overall = 0.84 among 4 BMI classes).
← all excerpts
Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma.
1
—
—